Welcome to the Vaccines and Immunizations website.
Skip directly to the search box, site navigation, or content.

Department of Health and Human Services
Centers for Disease Control and Prevention

Vaccines & Immunizations

News and Media Resources:

2005 Immunization News

On This Page:

December 2005

top of page

November 2005

  • MMWR logo November 25, 2005
    Conclusions and Recommendations of the Advisory Committee on Poliomyelitis Eradication — Geneva, Switzerland, October 2005
    The second meeting of the ACPE was convened in Geneva, Switzerland, on October 11-12, 2005, to provide WHO and the Global Polio Eradication Initiative with advice on program policies for 1) interrupting wild poliovirus (WPV) transmission worldwide, 2) limiting the international spread of circulating polioviruses, and 3) refining the program of work for eventual cessation of immunization with oral poliovirus vaccine (OPV). This report summarizes the results of that meeting...
  • MMWR logo November 18, 2005
    Immunization Information System Progress — United States, 2004
    One of the national health objectives for 2010 is to increase to at least 95% the proportion of children aged <6 years who participate in fully operational, population-based immunization registries (objective no. 14-26)...
  • e Family Practice News  Nov. 15, 2005 (Vol 35, No. 22)
    Pandemic Flu Plan Aims to Ramp Up Vaccine Industry (exit)
    ...The government's plan puts a strong emphasis on developing the capacity to produce influenza vaccine, rather than just focusing on stockpiling...
  • MMWR logo November 11, 2005
    Fifth International Conference on Emerging Infectious Diseases
    CDC, the American Society for Microbiology, the Council of State and Territorial Epidemiologists, the Association of Public Health Laboratories, and the World Health Organization will cosponsor the Fifth International Conference on Emerging Infectious Diseases, March 19-22, 2006, at the Marriott Marquis Hotel in Atlanta, GA...
  • MMWR logo November 4, 2005
    Global Measles and Rubella Laboratory Network, January 2004-June 2005
    Measles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide...
  • e Family Practice News Nov. 1, 2005 (Vol 35, No. 21)
    HPV Vaccine Prevents Early Cervical Cancer (exit)
    A multinational study of 11,502 young women showed for the first time that a vaccine for human papillomavirus can prevent precancerous cervical lesions and early in situ cervical cancers, Laura A. Koutsky, Ph.D., reported...

top of page

October 2005

  • MMWR logo October 28, 2005
    Import-Associated Measles Outbreak — Indiana, May-June 2005
    On May 29, 2005, the Indiana State Department of Health (ISDH) was notified of suspected measles in a female Indiana resident aged 6 years who was hospitalized in Cincinnati, Ohio, where she had been visiting relatives. Serologic analyses performed by the Ohio State Department of Health Laboratory and a private reference laboratory confirmed the diagnosis of measles...
  • MMWR logo October 21, 2005
    Poliovirus Infections in Four Unvaccinated Children — Minnesota, August-October 2005
    On October 14, this report was posted as an MMWR Dispatch on the MMWR website. On September 29, 2005, the Minnesota Department of Health (MDH) identified poliovirus type 1 in an unvaccinated, immunocompromised infant girl aged 7 months (the index patient) in an Amish community whose members predominantly were unvaccinated for polio...
  • MMWR logo October 21, 2005
    Influenza Vaccination in Pregnancy: Practices Among Obstetrician-Gynecologists — United States, 2003-04 Influenza Season
    To assess understanding of the ACIP recommendations among OB/GYNs, the American College of Obstetricians and Gynecologists (ACOG), with support from CDC, surveyed a national sample of OB/GYNs in May 2004. This report describes the results of that survey...
  • MMWR logo October 21, 2005
    Influenza Vaccination Levels Among Persons Aged >65 Years and Among Persons Aged 18-64 Years with High-Risk Conditions — United States, 2003
    Influenza vaccination is an effective tool for preventing hospitalization and death among persons aged 65 years and older, and among persons aged 18-64 years with medical conditions that increase the risk for influenza-related complications...
  • e Family Practice News Oct. 15, 2005 (Vol 35, No. 20)
    CDC Calls on Doctors to Line Up Early for Flu Shots (exit)
    Doctors, get your flu shots. Get vaccinated for your patients, do it for yourselves, “do it in droves, just do it,” William Schaffner, M.D., of the NFID, said at a press conference. Julie L. Gerberding, M.D., director of the CDC, stressed the importance of influenza vaccination for everyone.
  • MMWR logo October 14, 2005
    Poliovirus Infections in Four Unvaccinated Children — Minnesota, August-October 2005
    On September 29, 2005, the Minnesota Department of Health (MDH) identified poliovirus type 1 in an unvaccinated, immunocompromised infant girl aged 7 months (the index patient) in an Amish community whose members predominantly were unvaccinated for polio...
  • MMWR logo October 14, 2005
    FDA Approval of VAQTA® (Hepatitis A Vaccine, Inactivated) for Children Aged >1 Year
    On August 11, 2005, the FDA approved an application of a pediatric/adolescent formulation of VAQTA® for use among persons aged 12 months-18 years. Previously, the pediatric/adolescent formulation of VAQTA was approved for use in persons aged 2-18 years...
  • MMWR logo October 14, 2005
    QuickStats: Rate of Hospitalizations for Pertussis Among Infants Aged <6 Months United States, 1994-1998 and 1999-2003
    More than 90% of hospitalizations for pertussis among children aged <2 years occurred in infants aged <6 months, a group too young either to receive vaccination or to have developed adequate protection from vaccination. The pertussis hospitalization rate for infants aged <6 months increased by 20% from 1994-1998 to 1999-2003.
  • MMWR logo October 14, 2005
    Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine -- United States, June-July 2005
    As of October 4, 2005, the Vaccine Adverse Event Reporting System (VAERS) received five reports of Guillain-Barré syndrome (GBS) in persons after receipt of MCV4 vaccination. This report describes the clinical and epidemiologic features of these five cases and summarizes preliminary data from ongoing studies...
  • MMWR logo October 7, 2005
    Distribution of Insecticide-Treated Bednets During an Integrated Nationwide Immunization Campaign — Togo, West Africa, December 2004
    During December 13-19, 2004, Togo, a West African nation with a population of approximately 5 million, conducted the first-ever nationwide distribution of insecticide-treated bednets (ITNs) for prevention of malaria...
  • MMWR logo October 6, 2005
    Guillain-Barré Syndrome Among Recipients of Menactra® Meningococcal Conjugate Vaccine—United States, June-July 2005
    On January 14, 2005, a quadrivalent (A, C, Y, and W135) meningococcal conjugate vaccine (Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine, Menactra®, Sanofi-Pasteur, Swiftwater, Pennsylvania) (MCV4) was licensed in the United States...
  • Emerging Infectious Diseases logo October 2005 issue (Vol. 11, No. 10)
    Poultry-handling Practices during Avian Influenza Outbreak, Thailand
    With poultry outbreaks of avian influenza H5N1 continuing in Thailand, preventing human infection remains a priority. We surveyed residents of rural Thailand regarding avian influenza knowledge, attitudes, and practices. Results suggest that public education campaigns have been effective in reaching those at greatest risk, although some high-risk behavior continues...

top of page

September 2005

top of page

August 2005

  • Emerging Infectious Diseases logo August 2005 issue (Vol. 11, No. 8)
    Influenza A H5N1 Detection
    ...developed a sensitive and rapid real-time reverse transcription-polymerase chain reaction (RT-PCR) assay to detect influenza A H5N1 virus in clinical samples. This assay was evaluated with samples from H5N1-infected patients and demonstrated greater sensitivity and faster turnaround time than nested RT-PCR...
  • Emerging Infectious Diseases logo August 2005 issue (Vol. 11, No. 8)
    Influenza A (H3N2) Outbreak, Nepal
    In July 2004, an outbreak of influenza A (H3N2) was detected at 3 Bhutanese refugee camps in southeastern Nepal. Hemagglutination inhibition showed that about 40% of the viruses from this outbreak were antigenically distinct from the A/Wyoming/3/03 vaccine strain. Four amino acid differences were observed in most of the 26 isolates compared with the A/Wyoming/3/2003 vaccine strain...
  • Emerging Infectious Diseases logo August 2005 issue (Vol. 11, No. 8)
    Cost-Benefit of Stockpiling Drugs for Influenza Pandemic
    ...analyzed strategies for the use of stockpiled antiviral drugs in the context of a future influenza pandemic and estimated cost-benefit ratios. Current stockpiling of oseltamivir appears to be cost-saving to the economy under several treatment strategies, including therapeutic treatment of patients and postexposure prophylactic treatment of patients' close contacts...

top of page

July 2005

  • MMWR logoJuly 29, 2005
    Immunization Information System Progress -- United States, 2003
    This report summarizes data from CDC's 2003 Immunization Registry Annual Report (IRAR), a survey of IIS grantees in 50 states, five cities, and D.C. that receive funding under section 317b of the Public Health Service Act. The findings of the 2003 IRAR indicate that approximately 44% of U.S. children aged <6 years participated in an IIS...
  • MMWR logoJuly 29, 2005
    National, State, and Urban Area Vaccination Coverage Among Children Aged 19-35 Months -- United States, 2004
    This report summarizes results from the 2004 NIS, which indicated nationwide increases in coverage with at least 1 dose of varicella vaccine, PCV, and the 4:3:1, 4:3:1:3:3, and 4:3:1:3:3:1 vaccine series. These levels represent an important accomplishment by exceeding for the first time the Healthy People 2010 goal of >80% coverage for the 4:3:1:3:3 vaccine series...
  • MMWR logoJuly 29, 2005
    Erratum: Vol. 54, No. RR-8 for this MMWR:
    Prevention and Control of Influenza
    This report updates the 2004 recommendations by the ACIP regarding the use of influenza vaccine and antiviral agents (MMWR 2004;53[No. RR-6]:1-40). The 2005 recommendations include new or updated info. regarding 1) vaccination of persons with conditions leading to compromise of the respiratory system; 2) vaccination of healthcare workers; 3) clarification of the role of LAIV in vaccine shortage situations; 4) the 2005-06 trivalent vaccine virus strains...; and 5) the assessment of vaccine supply, timing of influenza vaccination, and prioritization of inactivated vaccine in shortage situations...
  • MMWR logoJuly 15, 2005
    Erratum: Vol. 54 / Early Release — Prevention and Control of Influenza
    In the Early Release, "Prevention and Control of Influenza: Recommendations of the Advisory Committee on Immunization Practices," an error occurred on page 20, in the section "Vaccination Before October."...
  • MMWR logoJuly 13, 2005
    Prevention and Control of Influenza: Recommendations of the ACIP
    Each year, the ACIP provides updated recommendations on influenza vaccination. This year, the recommendations include information regarding vaccination of persons with conditions leading to compromise of the respiratory system; vaccination of health-care workers...
  • MMWR logoJuly 8, 2005
    Progress Toward Poliomyelitis Eradication - India, January 2004-May 2005
    Since 1988, the global incidence of polio has decreased by more than 99%, and three World Health Organization (WHO) regions (Americas, Western Pacific, and European) have been certified as polio-free...
  • July 6, 2005
    Influenza Vaccines (Trivalent) Added to the VICP
    Individuals thought to be injured by the trivalent influenza vaccines are eligible for compensation from the National VICP as of July 1, 2005. This coverage permits people who think that they have been injured by this vaccine to file a claim for compensation.
  • e Family Practice News July 1, 2005 (Vol 35, No. 13)
    "Potent Zoster Vaccine Cuts Shingles Rate by Half"
    A potent live zoster vaccine halved the incidence of herpes zoster and reduced its disease burden and complications even more dramatically in a large study of adults aged 60 years and older...
  • MMWR logoJuly 1, 2005
    Update: Influenza Activity for 2004-05 Season -- U.S. and Worldwide
    During the 2004-05 season, influenza A (H1),* A (H3N2), and B viruses cocirculated worldwide, and influenza A (H3N2) viruses predominated... In the U.S., the 2004-05 influenza season peaked in February, was moderate, and was associated predominantly with influenza A (H3N2) viruses...
  • Emerging Infectious Diseases logo July 2005 issue (Vol. 11, No. 7)
    SARS Vaccine Development
    Developing effective and safe vaccines is urgently needed to prevent infection by severe acute respiratory syndrome (SARS)–associated coronavirus (SARS-CoV). The inactivated SARS-CoV vaccine may be the first one available for clinical use because it is easy to generate; however, safety is the main concern...
  • Preventing Chronic Disease logo July 2005 issue (Vol. 2, No. 3)
    Are Older Adults Up-to-Date With Cancer Screening and Vaccinations?
    Public health organizations in the United States emphasize the importance of providing routine screening for breast cancer, cervical cancer, and colorectal cancer, as well as vaccinations against influenza and pneumococcal disease among older adults...

top of page

June 2005

  • MMWR logoJune 17, 2005
    Progress in Measles Control -- Zambia, 1999-2004
    This report summarizes progress in measles control in Zambia during 1999-2004, as measured through surveillance data, which demonstrates a marked reduction in measles transmission after the 2003 SIA...
  • MMWR logoJune 3, 2005
    Surveillance for Laboratory-Confirmed, Influenza-Associated Hospitalizations
    The number of annual hospitalizations for influenza and pneumonia associated with influenza viruses in the United States is estimated at 95,000; however, no state-based or national surveillance system exists to monitor these events in all age groups, and population-based numbers of laboratory-confirmed, influenza hospitalizations are unknown...
  • MMWR logoJune 3, 2005
    Assessment of the Distinctions Between Public Health Practice and Research
    The Council of State and Territorial Epidemiologists (CSTE) has released a report, Public Health Practice vs. Research: A Report for Public Health Practitioners Including Cases and Guidance for Making Distinctions...
  • MMWR logo June 3, 2005
    New Edition of Health Information for International Travel
    CDC announces the availability of the 2005--2006 edition of Health Information for International Travel (i.e., the Yellow Book). This edition, which has been completely revised, updated, and reorganized, now includes references listed at the end of each section...

top of page

May 2005

  • MMWR logoMay 27, 2005
    Prevention and Control of Meningococcal Disease
    CDC’s Advisory Committee on Immunization Practices (ACIP) recommends routine vaccination of persons aged 11–12 years with the new tetravalent meningococcal polysaccharide-protein conjugate vaccine (MCV4) at the preadolescent healthcare visit (age 11–12 years). This report discusses the new vaccine recommendation, updates previous reports from ACIP concerning prevention and control of meningococcal disease, and provides updated recommendations regarding use of the tetravalent meningococcal polysaccharide vaccine (MPSV4) and on antimicrobial chemoprophylaxis...
  • MMWR logoMay 13, 2005
    Hepatitis Awareness Month
    May is Hepatitis Awareness Month. In 2003, in the United States, an estimated 61,000 new infections occurred with hepatitis A virus, 73,000 with hepatitis B virus, and 30,000 with hepatitis C virus...
  • Emerging Infectious Diseases logo May 2005 issue (Vol. 11, No. 5)
    Vaccine–derived Poliovirus, Thailand, 2003
    Repoted cases in April of 2003 of poliovirus in spite of the last polio case being reported in April 1997.

top of page

April 2005

  • MMWR logoApril 29, 2005
    Progress Toward Interruption of Wild Poliovirus Transmission - Worldwide, January 2004-March 2005
    This report describes global efforts to eradicate polio during January 2004-March 2005 and outlines remaining challenges to interrupting transmission in countries where polio remains endemic or transmission has been reestablished...
  • MMWR logoApril 22 , 2005
    Summary of Notifiable Diseases, 2003
     contains the official statistics, in tabular and graphic form, for the reported occurrence of nationally notifiable diseases in the United States for 2003. The data are final totals for 2002 reported as of June 30, 2004, unless otherwise noted...
  • MMWR logoApril 15, 2005
    National Infant Immunization Week - April 24-30, 2005
    National Infant Immunization Week (NIIW) is April 24-30, 2005. The theme this year is "Vaccination: an Act of Love. Love Them. Protect Them. Immunize Them." This annual event emphasizes the importance of timely infant and childhood vaccination, one of the most effective ways to protect infants and children from potentially serious diseases...
  • MMWR logoApril 8, 2005
    50th Anniversary of the First Effective Polio Vaccine - April 12, 2005
    April 12, 2005, marks the 50th anniversary of the announcement that the polio vaccine, developed by Jonas Salk and his team of scientists at the University of Pittsburgh, worked. "Safe, effective, and potent" were the words used to announce to the world that an effective vaccine had been found against a disease that once paralyzed 13,000-20,000 persons each year in the United States...
  • MMWR logoApril 8, 2005
    Update: Influenza Activity - U.S., 2004-05 Season
    This report summarizes influenza activity in the United States during October 3, 2004-March 26, 2005, updates the previous summary, and describes the composition of the 2005-06 influenza vaccine. Influenza activity was moderate in the United States overall, but varied by region. Preliminary data collected through the seven components of the CDC Influenza Surveillance System indicate that national influenza activity peaked in early February...

top of page

  • MMWR logoApril 1 , 2005
    Improving Influenza, Pneumococcal Polysaccharide, and Hepatitis B Vaccination Coverage Among Adults Aged <65 Years at High Risk
    The Task Force on Community Preventive Services conducted systematic reviews to evaluate the effectiveness of interventions to improve targeted vaccination coverage among adults aged <65 years at high risk when implemented alone and in combination with other interventions. Three targeted vaccinations recommended for populations at risk are addressed in this review: influenza, pneumococcal polysaccharide, and hepatitis B. This report provides additional information about population-based interventions to improve the coverage of influenza, pneumococcal polysaccharide, and hepatitis B vaccines among populations at risk, briefly describes how the reviews were conducted, and provides information that can help in applying the interventions locally...
  • MMWR logoApril 1 , 2005
    Estimated Influenza Vaccination Coverage Among Adults and Children -- U.S., September 1, 2004-January 31, 2005
    In response to the unexpected shortfall in the 2004-05 influenza vaccine supply, CDC recommended in October 2004 that vaccine be reserved for persons in certain priority groups. In late December 2004, based on declining demand among these groups, two additional groups were added to the list of vaccination priority groups. This report is based on analysis of data collected during February 1-27, 2005, regarding respondent-reported receipt of influenza vaccination during September 1, 2004-January 31, 2005...

top of page

March 2005

  • MMWR logoMarch 25, 2005
    Achievements in Public Health: Elimination of Rubella and Congenital Rubella Syndrome -- United States, 1969-2004
    In October 2004, CDC convened an independent panel of internationally recognized authorities on public health, infectious disease, and immunization to assess progress toward elimination of rubella and congenital rubella syndrome (CRS) in the United States, a national health objective for 2010. Since rubella vaccine licensure in 1969, substantial declines in rubella and CRS have occurred, and the absence of endemic transmission in the United States is supported by recent data. This report summarizes the history and accomplishments of the rubella vaccination program in the United States and the Western Hemisphere and the challenges posed by rubella for the future...
  • MMWR logoMarch 25, 2005
    Progress Toward Poliomyelitis Eradication -- Afghanistan and Pakistan, January 2004-February 2005
     Although poliomyelitis remained endemic in only six countries at the end of 2003, a resurgence of polio occurred in 2004, originating in Nigeria and resulting in the export of wild poliovirus into the polio-free countries of western and central Africa. This report summarizes progress toward polio eradication in Afghanistan and Pakistan during January 2004-February 2005 and indicates that, with continued support from national and local leaders, interruption of poliovirus transmission in both countries is feasible by the end of 2005...
  • MMWR logoMarch 25, 2005
    Varicella Surveillance in Public Elementary Schools -- Multnomah County, Oregon, 2002-2004
     To monitor changes in varicella incidence, Oregon Health Services and Multnomah Education Service District started routine, individual, case-based varicella surveillance in Multnomah County public elementary schools (kindergarten through 5th grade) beginning 2002-03. This report describes the surveillance system, the incidence of varicella, and the results of active surveillance...
  • MMWR logoMarch 25, 2005
    Varicella-Related Deaths -- United States, January 2003-June 2004
     During 2003 and the first half of 2004, CDC received reports of eight varicella-related deaths. The findings in this report underscore the importance of timely routine vaccination of children aged 12-18 months and catch-up vaccination of older susceptible children and adolescents according to current recommendations and the need for timely and complete national varicella death surveillance...

top of page

  • MMWR logoMarch 18, 2005
    Compendium of Animal Rabies Prevention and Control, 2005
     Rabies is a fatal viral zoonosis and a serious public health problem. The recommendations in this compendium serve as the basis for animal rabies prevention and control programs throughout the United States and facilitate standardization of procedures among jurisdictions, thereby contributing to an effective national rabies-control program. This document is reviewed annually and revised as necessary...
  • MMWR logoMarch 11, 2005
    Transmission of Hep B Virus Among Persons Undergoing Blood Glucose Monitoring in Long-Term-Care Facilities -- Mississippi, NC, and Los Angeles County, CA, 2003-2004
     Regular monitoring of blood glucose levels is an important component of routine diabetes care. Because of outbreaks of hepatitis B virus (HBV) infections associated with glucose monitoring, CDC and the FDA have recommended since 1990 that fingerstick devices be restricted to individual use. This report describes three recent outbreaks of HBV infection among residents in long-term care facilities that were attributed to shared devices and other breaks in infection-control practices related to blood glucose monitoring...

top of page

  • MMWR logoMarch 4 , 2005
    Update: Influenza Activity U.S., 2004-05 Season
     Influenza activity has increased steadily in the United States since late December 2004 and, as of February 19, 2005, might not have peaked. Laboratory-confirmed influenza infections have been reported from all 50 states. This report summarizes influenza activity during October 3, 2004-February 19, 2005...
  • MMWR logoMarch 4 , 2005
    Interventions to Increase Influenza Vaccination of Health-Care Workers - California and Minnesota
     Vaccination of healthcare workers (HCWs) has been shown to reduce influenza infection and absenteeism among HCWs, prevent mortality in their patients, and result in financial savings to sponsoring health institutions. However, influenza vaccination coverage among HCWs in the United States remains low. This report describes strategies implemented in three clinical settings that increased the proportion of HCWs who received influenza vaccination...
  • MMWR logoMarch 4 , 2005
    Progress in Reducing Measles Mortality - Worldwide, 1999-2003
     In the joint Strategic Plan for Measles Mortality Reduction, 2001-2005, the WHO and the United Nations Children's Fund targeted 45 priority countries for implementation of a comprehensive strategy for accelerated and sustained measles mortality reduction. This report updates progress toward this goal and summarizes recent recommendations on methods to estimate global measles mortality...

top of page

February 2005

  • MMWR logoFebruary 18, 2005
    Hepatitis A Vaccination Coverage Among Children Aged 24-35 Months - United States, 2003
    Hepatitis A vaccine was first licensed in the United States in 1995. In 1996, the Advisory Committee on Immunization Practices (ACIP) recommended vaccination of children aged >24 months in populations with the highest incidence of hepatitis A (e.g., American Indian/Alaska Native [AI/AN], Asian/Pacific Islander, and selected Hispanic and religious communities)... This report is the first national analysis of hepatitis A vaccination coverage among children...

top of page

January 2005

  • MMWR logoJanuary 28, 2005
    Fatal Case of Pertussis in an Infant - West Virginia, 2004
    In December 2004, an infant aged 29 days in West Virginia died from pertussis after exposure to adult family members with probable undiagnosed pertussis. Adolescents and adults, even those previously vaccinated as children, often have disease not recognized as pertussis. This report summarizes results of the West Virginia Department of Health and Human Resources (WVDHHR) case investigation...
  • MMWR logoJanuary 28, 2005
    Outbreak of Invasive Pneumococcal Disease - Alaska, 2003-2004
    In Alaska, statewide laboratory-based surveillance revealed an increase in invasive pneumococcal disease (IPD) in a rural region during 2003-2004. This report summarizes the outbreak, regional trends in serotype-specific pneumococcal carriage, and an assessment of use of standing orders for vaccination. The results of this analysis underscore the preventability of IPD and the importance of vaccination.

    top of page

  • MMWR logoJanuary 21, 2005
    Notice to Readers: Satellite Broadcast on Epidemiology and Prevention of Vaccine-Preventable Diseases
    CDC's NIP and the PHTN will present a live, four-part satellite broadcast series entitled "Epidemiology and Prevention of Vaccine-Preventable Diseases" on February 17 and 24 and March 3 and 10, 2005, from 12:00 noon to 3:30 p.m. EST. The series is intended for physicians, nurses, nurse practitioners, physician assistants, pharmacists, residents, medical and nursing students, and colleagues who either administer vaccinations or set policy in their workplaces.
  • MMWR logoJanuary 21, 2005
    Erratum: Vol. 54, No. 1
    In the report, Update: Influenza Activity - United States, 2004-05 Season, an error occurred on page 16 in the footnote linked to the bullet point, "Out-of-home caregivers and household contacts of persons with high-risk conditions†††." The footnote should read "Persons at high risk include adults aged >65 years, children aged 0-23 months, persons aged 2-64 years with underlying chronic medical conditions, women who will be pregnant during the influenza season, residents of nursing homes and long-term-care facilities, and children aged 2-18 years on chronic aspirin therapy."
  • MMWR logoJanuary 14, 2005
    Update: Influenza Activity - United States, 2004-05 Season
    Influenza activity was low in the United States during October through early December but has increased steadily since mid-December. Current surveillance indicators suggest that influenza activity for the season has not yet peaked. This report summarizes influenza activity during October 3, 2004-January 1, 2005* and provides information on the availability of additional influenza vaccine from GSK...
  • MMWR logoJanuary 7, 2005
    Recommended Childhood and Adolescent Immunization Schedule - United States, 2005
     Recommendations and format of the childhood and adolescent immunization schedule for July-December 2004 were approved by ACIP, the AAFP, and the AAP and were published in April 2004.The childhood and adolescent immunization schedule for 2005 is unchanged from that published in April 2004...
  • Emerging Infectious Diseases logo January 2005 issue (Vol. 11, No. 1) HEPA/Vaccine Plan for Anthrax Remediation
    In addition to killing 5 of its 11 victims, the 2001 anthrax attack on the U.S. Postal Service and federal facilities also contaminated a number of buildings. The U.S. government spent several hundred million dollars recovering buildings with large-area contamination by using chlorine dioxide fumigation...

top of page

 Return to Immunization News main page

Non-CDC Link Disclaimer: Links to non-Federal organizations found at this site are provided solely as a service to our users. These links do not constitute an endorsement of these organizations or their programs by CDC or the Federal Government, and none should be inferred. The CDC is not responsible for the content of the individual organization web pages found at these links.

This page last modified on December 26, 2007
This page archived for historical purposes January 30, 2007
Content Source: National Center for Immunization and Respiratory Diseases

Quick Links

Safer Healthier People

Centers for Disease Control and Prevention 1600 Clifton Rd, Atlanta, GA 30333, U.S.A
Public Inquiries: 1-800-CDC-INFO (232-4636); 1-888-232-6348 (TTY)

Vaccines and Immunizations